Lingua: Inglese
Editore: LAP LAMBERT Academic Publishing Mai 2018, 2018
ISBN 10: 6139832136 ISBN 13: 9786139832132
Da: buchversandmimpf2000, Emtmannsberg, BAYE, Germania
EUR 35,90
Quantità: 2 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. Neuware -Book focus to determine the CD20 protein expression in B-cell lymphoma cancer. The aim and objective are as follows: To study the incidence of CD20 in B-cell lymphoma. To evaluate expression of CD20 protein on paraffin embedded tissue sections by Immunohistochemical analysis in B-cell lymphoma. Immunohistochemical analysis is advantageous because the antigen expression can be studied within the cancer cells. To correlate CD20 expression with established clinico-pathological parameters, and understanding antiCD20 therapy on B-cell lymphoma patients. It was assumed that data from the present study would provide better insight in to the role of CD20 in B-cell lymphoma patients, and further help in treatment planning of these patients.Books on Demand GmbH, Überseering 33, 22297 Hamburg 60 pp. Englisch.
Lingua: Inglese
Editore: LAP LAMBERT Academic Publishing, 2018
ISBN 10: 6139832136 ISBN 13: 9786139832132
Da: preigu, Osnabrück, Germania
EUR 33,20
Quantità: 5 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. CD20 Protein Expression and Anti CD 20 Therapy in Lymphoma Cancer | Ram Darshit | Taschenbuch | 60 S. | Englisch | 2018 | LAP LAMBERT Academic Publishing | EAN 9786139832132 | Verantwortliche Person für die EU: BoD - Books on Demand, In de Tarpen 42, 22848 Norderstedt, info[at]bod[dot]de | Anbieter: preigu.
Lingua: Inglese
Editore: LAP LAMBERT Academic Publishing Mai 2018, 2018
ISBN 10: 6139832136 ISBN 13: 9786139832132
Da: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germania
EUR 35,90
Quantità: 2 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Book focus to determine the CD20 protein expression in B-cell lymphoma cancer. The aim and objective are as follows: To study the incidence of CD20 in B-cell lymphoma. To evaluate expression of CD20 protein on paraffin embedded tissue sections by Immunohistochemical analysis in B-cell lymphoma. Immunohistochemical analysis is advantageous because the antigen expression can be studied within the cancer cells. To correlate CD20 expression with established clinico-pathological parameters, and understanding antiCD20 therapy on B-cell lymphoma patients. It was assumed that data from the present study would provide better insight in to the role of CD20 in B-cell lymphoma patients, and further help in treatment planning of these patients. 60 pp. Englisch.
Lingua: Inglese
Editore: LAP LAMBERT Academic Publishing, 2018
ISBN 10: 6139832136 ISBN 13: 9786139832132
Da: moluna, Greven, Germania
EUR 31,27
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Darshit RamProf. Ram DarshitB. Pharm from B. K. Mody Govt. Pharmacy College, Rajkot, M. Pharm from DPS, Rajkot, in the specialization (Pharmaceutical Biotechnology), and his PhD is continue from RK university, Rajkot. Currently worki.
Lingua: Inglese
ISBN 10: 6139832136 ISBN 13: 9786139832132
Da: Biblios, Frankfurt am main, HESSE, Germania
EUR 55,25
Quantità: 4 disponibili
Aggiungi al carrelloCondizione: New. PRINT ON DEMAND.
Da: AHA-BUCH GmbH, Einbeck, Germania
EUR 37,20
Quantità: 1 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Book focus to determine the CD20 protein expression in B-cell lymphoma cancer. The aim and objective are as follows: To study the incidence of CD20 in B-cell lymphoma. To evaluate expression of CD20 protein on paraffin embedded tissue sections by Immunohistochemical analysis in B-cell lymphoma. Immunohistochemical analysis is advantageous because the antigen expression can be studied within the cancer cells. To correlate CD20 expression with established clinico-pathological parameters, and understanding antiCD20 therapy on B-cell lymphoma patients. It was assumed that data from the present study would provide better insight in to the role of CD20 in B-cell lymphoma patients, and further help in treatment planning of these patients.